Abstract
Mesenchymal stem cells (MSC) are multipotent stem cells that display the capacity to generate the tissue in which they reside. MSC have been used as progenitor cells to engineer cartilage implants that can be used to repair chondral and osteochondral lesions, or as trophic producers of bioactive factors to initiate endogenous regenerative activities in the arthritic joint. Targeted gene therapy might further enhance the capacity of MSC for chondrogenesis. By using a clustered regularly interspaced short palindromic repeats/CRISPR-associated protein genomic manipulation technique, target-gene-modified MSC would be a promising therapeutic option for regeneration of diseased joints in the treatment of RA.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu S, Maeyama K (2016) Gene therapy for rheumatoid arthritis. Crit Rev Immunol 36:149–161
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26
Chen FH, Rousche KT, Tuan RS (2006) Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2:373–382
Luz-Crawford P, Espinosa-Carrasco G, Ipseiz N, Contreras R, Tejedor G, Medina DA et al (2018) Gilz-Activin A as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay. Theranostics 8:846–859
Luz-Crawford P, Jorgensen C, Djouad F (2017) Mesenchymal stem cells direct the immunological fate of macrophages. Results Probl Cell Differ 62:61–72
Barry F, Murphy M (2013) Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 9:584–594
Hu B, Ren JL, Zhang JR, Ma Q, Liu YP, Mao TQ (2010) Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model. J Tissue Eng Regen Med 4:105–114
Qi Y, Feng G, Yan W (2012) Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 39:5683–5689
Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005) Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52:2521–2529
Hatsushika D, Muneta T, Nakamura T, Horie M, Koga H, Nakagawa Y et al (2014) Repetitive allogeneic intraarticular injections of synovial mesenchymal stem cells promote meniscus regeneration in a porcine massive meniscus defect model. Osteoarthr Cartil 22:941–950
Hochheiser K, Kueh AJ, Gebhardt T, Herold MJ (2018) CRISPR/Cas9: a tool for immunological research. Eur J Immunol 48:576–583
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liu, S. (2018). Mesenchymal Stem Cell Engineering. In: Liu, S. (eds) Rheumatoid Arthritis. Methods in Molecular Biology, vol 1868. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8802-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8802-0_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8801-3
Online ISBN: 978-1-4939-8802-0
eBook Packages: Springer Protocols